# Prevention of Female Cancers by Optimization of Selenium Levels in the Organism.

> **NCT04014283** · NA · UNKNOWN · sponsor: **Read-Gene S.A.** · enrollment: 7000 (estimated)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DIETARY_SUPPLEMENT:** Selenium supplementation or placebo treatment
- **OTHER:** Diet modification
- **OTHER:** Selenium supplementation or placebo treatment and diet modification

## Key facts

- **NCT ID:** NCT04014283
- **Lead sponsor:** Read-Gene S.A.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2023-11
- **Final completion:** 2023-11
- **Target enrollment:** 7000 (ESTIMATED)
- **Last updated:** 2023-04-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04014283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04014283, "Prevention of Female Cancers by Optimization of Selenium Levels in the Organism.". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT04014283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*